Linfomas extranodales en el área metropolitana de Bucaramanga: 2000-2004

dc.contributor.advisorCamacho López, Rafael Miguel
dc.contributor.advisorAcevedo Jurado, Diana Josefina
dc.contributor.authorUribe Pérez, Claudia Janethspa
dc.contributor.authorGarcía Ramírez, Carlos Albertospa
dc.contributor.authorMeza Durán, Erika Elianaspa
dc.contributor.cvlacUribe Pérez, Claudia Janeth [0000267848]
dc.contributor.cvlacGarcía Ramírez, Carlos Alberto [0000042722]
dc.contributor.googlescholarUribe Pérez, Claudia Janeth [hx8PM4AAAAAJ]
dc.contributor.researchgroupGrupo de Estudio Genético de Enfermedades Complejasspa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa
dc.contributor.scopusUribe Pérez, Claudia Janeth [55546023800]
dc.date.accessioned2020-10-27T14:20:46Z
dc.date.available2020-10-27T14:20:46Z
dc.date.issued2009-04-11
dc.description.abstractAntecedentes: Los linformas estranodales (LEN) se localizan en cualquier sitio diferente a los ganglios linfáticos, como el tracto gastrointestinal (TGL) y la piel; la mayoría son de tipo linfoma no Hodgkin (LNH). Representa entre el 2545% de todos los LNH, y el subtipo histopatológico más frecuente corresponde a linfoma difuso de células B grandes (LDCBG). El objetivo de este estudio es identificar algunas características socio-demográficas de los pacientes de linfomas extranodales residentes en el área Metropolitana de Bucaramanga (AMB), así como otras características propias de los LEN. Metodología: usando los datos recolectados en el RPC-AMB se calcularon frecuencias de algunas variables (Sexo, Edad, localización anatómica tipo hispatológico) de los LEN. Resultados: Entre los años 2000-2004 se detectaron 247 casos de linfomas; 72(29%) correspondieron a LEN. El 58% de los ocurrieron en hombres y el 42% en mujeres. Se encontró predominio de la enfermedad en la 6* y 7* década de la vida. Los sitios de mayor presentación fueron TGI (29%), piel (14%), y tejidos blandos (14%). Las clasificaciones más frecuentes para los LEN fueron LNH-NOS (no especificado) (27.7%) y linfoma difuso de células B grandes (19.4%). Conclusiones: Se encontraron semejanzas en las características de los LEN-NH comparados con los datos registrados a nivel mundial. Es necesario promover la implementación de métodos diagnósticos avanzados para este tipo de neoplacias.[Uribe CJ, García CA, Meza EE, Camacho RM, Acevedo DJ. Linfomas eztranodales en el área metropolitana de Bucaramanga: 2000-2004. MedUNAB 2009; 12:19-21].spa
dc.description.abstractenglishBackground: Stranodal lymph nodes (LEN) are located anywhere other than the lymph nodes, such as the gastrointestinal tract (GLT) and the skin; most are non-Hodgkin lymphoma (NHL). It represents between 2545% of all NHL, and the most frequent histopathological subtype corresponds to diffuse large B-cell lymphoma (LDCBG). The objective of this study is to identify some socio-demographic characteristics of extranodal lymphoma patients residing in the Metropolitan area of ​​Bucaramanga (AMB), as well as other characteristics typical of LEN. Methodology: using the data collected in the RPC-AMB, frequencies of some variables (Sex, Age, hispathological anatomical location) of the LEN were calculated. Results: Between the years 2000-2004, 247 cases of lymphomas were detected; 72 (29%) corresponded to LEN. 58% of them occurred in men and 42% in women. A predominance of the disease was found in the 6th and 7th decade of life. The sites of greatest presentation were GIT (29%), skin (14%), and soft tissues (14%). The most frequent classifications for LEN were NHL-NOS (unspecified) (27.7%) and diffuse large B-cell lymphoma (19.4%). Conclusions: Similarities were found in the characteristics of the LEN-NH compared to the data recorded worldwide. It is necessary to promote the implementation of advanced diagnostic methods for this type of neoplacia [Uribe CJ, García CA, Meza EE, Camacho RM, Acevedo DJ. Eztranodal lymphomas in the metropolitan area of ​​Bucaramanga: 2000-2004. MedUNAB 2009; 12: 19-21]eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10286
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programPregrado Derecho
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/46/43
dc.relation.referencesEconomopoulos T, Papageorgiou S, Rontogianni D. Multifocal extranodal non-Hodgkin lymphoma. Αclinicopathologic study of 37 cases in Greece. AHellenic Cooperative Oncology Group Study. Oncologist 2005; 10:734-8
dc.relation.referencesTemmim L, Baker H, Amanguno H, Madda JP, Sinowatz F. Clinicopathological features of extranodal lymphomas: Kuwait experience. Oncology 2004; 67:382-9
dc.relation.referencesFujita A, Tomita N, Fujita H, Motohashi K, Hyo R, Yama-zaki E, et al. Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 2009; 26:49-54
dc.relation.referencesGurney KA, Cartwright RA. Increasing incidence and des-criptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 2002; 3:95-104
dc.relation.referencesNewton R , Ferlay J , Beral V, Devesa S. The epidemiology of non-Hodgkin's lymphoma: Comparison of nodal and extra-nodal sites. Int J Cancer 1997; 72:923-30
dc.relation.referencesOtter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. Asurvey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25:1203-10
dc.relation.referencesGroves FD, Linet MS, Travis LB, Devesa SS. Cancer sur-veillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92:1240-51
dc.relation.referencesPsyrri A, Papageorgiou S, Economopoulos T. Primary extra-nodallymphomasofstomach:clinicalpresentation,diagnostic pitfalls and management. Ann Oncol 2008; 19:1992-9
dc.relation.referencesVose J, Chiu B, Cheson BD, Dancey J, Wright J. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematol Am Soc Educ Program 2002: 241-62
dc.relation.referencesUribe CJ, Meza EE, Gómez NJ. Incidencia de neoplasias hematológicas en el Área Metropolitana de Bucaramanga, 2000-2004. MedUNAB 2008; 11:76-82
dc.relation.referencesUribe CJ, Meza EE. Incidencia de cáncer en el Área Metropoli-tana de Bucaramanga, 2000-2004. MedUNAB 2007;10:147-72
dc.relation.referencesYustein JT, Dang CV. Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol 2007 14:375-81
dc.relation.referencesFerry JA. Extranodal lymphoma. Arch Pathol Lab Med 2008; 132:565-78
dc.relation.referencesAssaf C, Gellrich S, Steinhoff M, Nashan D. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology. J Dtsch Dermatol Ges 2007;5:662-8
dc.relation.referencesCriscione VD, Weinstock M. Incidence of cutaneous T-Cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143:854-9
dc.relation.referencesBray F, Pisani P, Darkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Version 2.0, IARC Press, Lyon, 2004
dc.relation.referencesArcan A, Dincol D, Akbulut H, Onur H, Demirkazk A, Cay F, et al. Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey. Am J Clin Oncol 1999; 1999; 22:587-92
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/46
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 12 Núm. 1 (2009): Antiprotozoarios, Memoria y emoción, Consentimiento informado; 19-21
dc.subjectCiencias de la salud
dc.subjectMedicina
dc.subjectCiencias médicas
dc.subjectCiencias biomédicas
dc.subjectCiencias de la vida
dc.subjectInnovaciones en salud
dc.subjectInvestigaciones
dc.subject.keywordsHealth Scienceseng
dc.subject.keywordsMedicineeng
dc.subject.keywordsMedical Scienceseng
dc.subject.keywordsBiomedical Scienceseng
dc.subject.keywordsLife Scienceseng
dc.subject.keywordsInnovations in healtheng
dc.subject.keywordsResearcheng
dc.subject.keywordsHematologic neoplasm
dc.subject.keywordsMedical topography
dc.subject.keywordsAnatomy
dc.subject.keywordsRegistries
dc.subject.lembPatología
dc.subject.lembDemografía
dc.subject.proposalEnfermedades hematológicas
dc.subject.proposalTopografía
dc.subject.proposalMorfología
dc.subject.proposalPoblación
dc.titleLinfomas extranodales en el área metropolitana de Bucaramanga: 2000-2004
dc.title.translatedExtranodal lymphomas in the metropolitan area of ​​Bucaramanga: 2000-2004eng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversionInfo:eu-repo/semantics/publishedVersion
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
2009_Linfomas_extranodales_en_el_área_metropolitana_de_Bucaramanga.pdf
Tamaño:
705.25 KB
Formato:
Adobe Portable Document Format
Descripción:
Articulo